Amikacin pharmacokinetics during continuous ambulatory peritoneal dialysis.

The pharmacokinetics of amikacin were investigated in five stable patients undergoing continuous ambulatory peritoneal dialysis (CAPD). Each patient was studied after the administration of 7.5 mg of amikacin per kg by both the intravenous (i.v.) and intraperitoneal (i.p.) route, allowing a 1-month w...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	Antimicrob Agents Chemother
Päätekijät:	Smeltzer, B D, Schwartzman, M S, Bertino, J S
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Microbiology (ASM) 1988
Aiheet:	Research Article
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC172141/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3364945/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.32.2.236
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!